GE HealthCare Korea said it has signed a business agreement with LG Electronics and Microsoft Korea to innovate the healthcare industry and develop and build smart hospitals.GE HealthCare Korea CEO Kim Yong-duk, Microsoft Korea CEO Cho Won-woo and LG Electronics Vice President for Business Solutions
KBIOHealth (Osong Medical Innovation Foundation) has set up an office in Japan, raising expectations of cooperation between the two countries’ biotech industries.KBIOHealth said it opened an office (KBIOHealth JAPAN Office) in Shonan iPark, located in Kanagawa Prefecture, and held a signboard-hangin
Doctors from 50 countries will visit Korea amid mounting concern over the increase in medical students and an essential care crisis, as the World Medical Association (WMA) holds its 226th Council meeting in Seoul from April 18 to 20.To commemorate the occasion, the Korean Medical Association (KMA) w
Recent advancements in HIV treatment and prevention, including the roll-out of pre-exposure prophylaxis (PrEP) and the bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) treatment regimen, have highlighted the critical need for ethnic-centered approaches in healthcare.Therefore, understanding
Korea’s main opposition Democratic Party secured a landslide victory in Wednesday's parliamentary election. As conservative President Yoon Suk Yeol and his ruling party are expected to face an uphill battle in the political scene, many now pay attention to whether there will be any change in the gov
Watson & Company's mental wellness electroceutical tool, Pocus, is receiving attention from industry watchers and the public after showcasing its potential at the 2022 Hangzhou Asian Games, where athletes used it to manage stress and improve sleep quality.Pocus is a wearable device that applies neur
"A general material," or "Takes after mom."Obstetricians have made such vague remarks, providing only speculative indirect information to parents who wondered about fetal sex.From now on, however, they can directly tell whether the fetus is a boy or a girl.That’s because the Constitutional Court rec
LifeSemantics said Tuesday that it has received approval from the Ministry of Food and Drug Safety (MFDS) to conduct a confirmatory clinical trial of its cardiovascular risk (hypertension complications) assessment AI software.The clinical trial will be a retrospective analytical study utilizing bloo
Young physicians from overseas have voiced their support for the resignations and allied leave of absence by Korean trainee doctors and medical students protesting the medical school enrollment quota increase.They also called for the Korean government to stop administrative penalties for collective
GI Innovation is accelerating the development of a subcutaneous (SC) formulation of its immuno-oncology candidate GI-102.The company said Tuesday that it has applied for approval to change the IND (investigational new drug) application for the GI-102 phase 1/2a clinical trial to the Ministry of Food
Saruparib, a next-generation PARP inhibitor in development by AstraZeneca, has garnered attention from cancer experts worldwide after showing clinical benefit in patients with homologous recombination repair-deficient (HRD) breast cancer.However, it is questionable whether Korean patients who face s
Curocell, a local chimeric antigen receptor-T (CAR-T) developer, said it will start developing a next-generation Anti-CD19 CAR-T therapy for treatment-resistant systemic lupus erythematosus (SLE) as part of the2024 Multi-Ministerial Regenerative Medicine Technology Development Program.This initiativ
Hugel, a total medical aesthetics company, said Tuesday that its polydioxanone (PDO) suture brand Licellvi (domestic product name: Blue Rose Forte) has received a product license from the Brazilian National Agency for Food and Drug Surveillance (ANVISA).Licellvi is a PDO suture brand of JWorld, a su
An increasing number of health supplements are differentiating themselves from traditional forms, such as capsules and pills, to various formulations, attempting to attract consumers with formulations that focus on portability and convenience of consumption.CJ ENM's digital marketing affiliate, Mezz
Menopausal women who experienced an early onset of vasomotor symptoms (VMSs), commonly known as hot flashes and night sweats, are at a higher risk of developing depressive symptoms, according to a study by Korean researchers.Professors Ryu Seung-ho, Chang Yoo-soo, and Dr. Choi Hye-rin at the Center
Daewoong Pharmaceutical said that it applied for product approval for Envlo, the first homegrown sodium-glucose cotransporter 2 (SGLT2) diabetes drug in Korea and the nation's 36th newly developed drug, to Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).COFEPRIS is
ViGenCell said Monday that it had initiated the Cohort 3 study, the final step of the phase 1 clinical trial of VT-Tri(1)-A for treating acute myeloid leukemia (AML).VT-Tri(1)-A is ViGenCell's first-in-class treatment for AML. It targets multiple common antigens. Last September, it began enrolling p
The Korea Exchange (KRX) has suspended stock trading of EONE-Diagnomics Genome Center (EDGC), a Kosdaq-listed genomic analysis company, due to unverified rumors that the company received a disclaimer of opinion during its audit process.The suspension took effect when the market opened Monday, with K
Celltrion said it has completed a registration contract for its subcutaneous (SC) Remicade biosimilar, Zymfentra (infliximab), with one of the top three pharmaceutical benefit managers (PBMs) in the United States."We are pleased to announce through our website that we have successfully closed a deal
The government said Monday that it would conduct an internal review of the Korean Medical Association (KMA)'s emergency committee's proposal to re-discuss increasing the number of medical students after a one-year moratorium.The government also said that although the enrollment quota has been alloca